Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Hepion Pharmaceuticals, Inc. (HEPA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Hepion Pharmaceuticals, Inc. (HEPA), most recent 12 months reported: net loss $3.19M. Latest balance sheet on file: liquid cash $1.63M. From SEC filings. Others in Pharmaceutical Preparations: Structure Therapeutics Inc. · Grace Therapeutics, Inc. · GRI BIO, INC. · GT Biopharma, Inc. · WEREWOLF THERAPEUTICS, INC. · TuHURA BIOSCIENCES, INC./NV · IMMIX BIOPHARMA, INC. · Immunome, Inc.

Stock screener

Watchlist